该小组也报道指出停用吡美莫司乳膏并不会导致随访期患者皮肤症状反弹。
Stopping pimecrolimus cream did not lead to a rebound of skin symptoms in most of the patients who entered the follow-up phase, they also report.
与预料一样，吡美莫司耐受性良好，该研究小组指出，吡美莫司没有严重的副作用。
As expected, pimecrolimus was well tolerated, the team reports, noting that there were no drug-related serious adverse effects.
吡美莫司治疗皮质类固醇激素诱导的口周皮炎患者尤为有效。吡美莫司治疗的患者生活质量改善比对照组多。
Pimecrolimus was most effective in patients with corticosteroid-induced POD. Pimecrolimus-treated patients reported greater gains in quality of life than control-treated patients.
吡美莫司治疗皮质类固醇激素诱导的口周皮炎患者尤为有效。吡美莫司治疗的患者生活质量改善比对照组多。
Pimecrolimus was most effective in patients with corticosteroid-induced POD. Pimecrolimus-treated patients reported greater gains in quality of life than control-treated patients.
应用推荐